WO1986003781A1 - Process for producing alginates having improved physical properties, and the use of said alginates - Google Patents
Process for producing alginates having improved physical properties, and the use of said alginates Download PDFInfo
- Publication number
- WO1986003781A1 WO1986003781A1 PCT/NO1985/000080 NO8500080W WO8603781A1 WO 1986003781 A1 WO1986003781 A1 WO 1986003781A1 NO 8500080 W NO8500080 W NO 8500080W WO 8603781 A1 WO8603781 A1 WO 8603781A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alginates
- alginate
- physical properties
- preparation
- improved physical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/24—Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
Definitions
- the present invention relates to the preparation of alginates having improved physical properties, especially with respect to the formation of gels having inorganic or polyvalent organic ions.
- Said modified alginates are intended to be used for immobilizing and encapsulating enzymes and/or cells for use in biotechnological processes .
- alginate gels as an immobilizing material has several deficiencies, two of them being:
- Calcium alginate gels are destabilized by compounds having affinity for calcium, for instance EDTA, citrate, lactate and phosphate, as well as high concentrations of
- + + ++ cations such as Na , K and Mg ;
- Alginates currently used have a high degree of chemical heterogenity and provide gels having pores of such great size that proteins - enzymes and other macro- molecules - can leach out, at the same time as the size distribution of the pores is difficult to control.
- Alginate is the most important structural poly- saccharide in marine brown algae and is used for several industrial purposes wherein the properties of the polymer are utilized as a polyelectrolyte - for instance for gel formation and thickening purposes - and also for its water and ion binding capacity.
- the purpose of the present invention is to prepare alginates having physical properties satisfying the requirements for increased gel strength and stability and better controllable pore size.
- alginate is a polyuronide built up from two uronic acids, viz., D-mannuronic acid ( ) and the C-5-epimer L-guluronic acid (G) . They are arranged in such fashion that the polymer is further built up from three types of sequence: (G)-rich sequences called G-blocks, (M)-rich sequences called M-blocks and alter ⁇ nating structure symbolized by ( G G G) .
- G-blocks G-blocks
- M-rich sequences called M-blocks
- alter ⁇ nating structure symbolized by ( G G G G) alter ⁇ nating structure symbolized by ( G G G G) .
- the alginate's ability to form a gel by ionic binding, and the properties of said gel depends both on the relative content of the two uronic acids and on the distribution of the guluronic acid units along the chain.
- a high content of (G) -blocks yields, for instance, an alginate with great gel-forming capacity, which, techni ⁇ cally seen, is a valuable property of the polymer.
- the present invention is based on the following:
- the alginate is synthesized in the alga as poly- mannuronic acid and is thereafter modified by an enzyme, mannuronan-C-5epimerase, which converts D-mannuronic acid residues into i-guluronic acid residues within the chain.
- an enzyme mannuronan-C-5epimerase, which converts D-mannuronic acid residues into i-guluronic acid residues within the chain.
- the invention relates to a process for producing alginates having improved physical properties such as increased gel strength, by using enzymatic modification on a polymeric level.
- the process is characterized in that alginates derived from brown algae or bacteria are inoculated with an enzyme preparation.
- an enzyme preparation is preferably used a C-5-epimerase preparation, more preferably an alginate lyase-free mannuronan-C-5-epimerase produced from the earth bacterium Azotobacter vinelandii.
- the present invention also comprises the use of the thus modified alginates for immobilizing enzymes, cell organelles and cells by entrapment in gels of alginate or alginate having suitable cations, as well as by immobi ⁇ lizing biocatalysts by encapsulation in alginate poly- cation microcapsules .
- the mannuronan-C-5-epimerase may be isolated from cultures from the earth bacterium Azotobacter vinelandii. which produces both alginate and epimerase extracellu- larily.
- the fact that the enzyme is extracellular is a great advantage in the isolation process, and it also indicates that the enzyme may function freely in solution independent on intracellular factors, which is favourable to a technical exploitation of the invention.
- Immobilized enzymes as catalysts has obtained still greater importance in industry and will, in the years to come, become one of the most important expansion areas for biotechnology. Immobilized enzymes are often more stable, but first and foremost, they are easier to handle than free, soluble enzymes and may be used in continuous processes.
- the cells may serve as carriers for a single enzyme, such that isolation of the enzyme is unnecessary before immobilizing, or several enzymes may also be used in the cell in order to catalyse multistep processes (for instance synthesis of hormones, proteins, etc.).
- the epimerization degree measured by means of high solution n.m. . -spectro- scopy, shows an increase of the guluronic acid content from 68% to 79% (see the Table) .
- composition and GG content of the polymer before and after enzymatic modification measured by 1 high solution H-n.m.r. -spectroscopy
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Process for producing alginates having improved physical properties, by the inoculation of alginates derived from brown algae or bacteria, with an enzyme preparation such as a mannuronan-C-5-epimerase preparation from Azotobacter vinelandii. The modified alginates are used for immobilizing enzymes, cell organelles or cells as well as for the microencapsulation of biocatalysts.
Description
Process for producing alginates having improved physical properties, and the use of said alginates.
The present invention relates to the preparation of alginates having improved physical properties, especially with respect to the formation of gels having inorganic or polyvalent organic ions. Said modified alginates are intended to be used for immobilizing and encapsulating enzymes and/or cells for use in biotechnological processes .
Using alginate gels as an immobilizing material has several deficiencies, two of them being:
1 ) Calcium alginate gels are destabilized by compounds having affinity for calcium, for instance EDTA, citrate, lactate and phosphate, as well as high concentrations of
+ + ++ cations such as Na , K and Mg ;
2) Alginates currently used have a high degree of chemical heterogenity and provide gels having pores of such great size that proteins - enzymes and other macro- molecules - can leach out, at the same time as the size distribution of the pores is difficult to control.
Alginate is the most important structural poly- saccharide in marine brown algae and is used for several industrial purposes wherein the properties of the polymer are utilized as a polyelectrolyte - for instance for gel formation and thickening purposes - and also for its water and ion binding capacity.
The purpose of the present invention, thus, is to prepare alginates having physical properties satisfying the requirements for increased gel strength and stability and better controllable pore size.
Chemically seen, alginate is a polyuronide built up from two uronic acids, viz., D-mannuronic acid ( ) and the C-5-epimer L-guluronic acid (G) . They are arranged in such fashion that the polymer is further built up from three types of sequence: (G)-rich sequences called G-blocks, (M)-rich sequences called M-blocks and alter¬ nating structure symbolized by ( G G G) .
The alginate's ability to form a gel by ionic binding, and the properties of said gel depends both on the relative content of the two uronic acids and on the distribution of the guluronic acid units along the chain.
A high content of (G) -blocks yields, for instance, an alginate with great gel-forming capacity, which, techni¬ cally seen, is a valuable property of the polymer.
The present invention is based on the following:
The alginate is synthesized in the alga as poly- mannuronic acid and is thereafter modified by an enzyme, mannuronan-C-5epimerase, which converts D-mannuronic acid residues into i-guluronic acid residues within the chain. When said enzyme affects the alginate, both the relative content and the uronic acid sequence will be changed and, consequently, its physical properties.
Thus, the invention relates to a process for producing alginates having improved physical properties such as increased gel strength, by using enzymatic modification on a polymeric level. The process is characterized in that alginates derived from brown algae or bacteria are inoculated with an enzyme preparation.
As such an enzyme preparation is preferably used a C-5-epimerase preparation, more preferably an alginate lyase-free mannuronan-C-5-epimerase produced from the earth bacterium Azotobacter vinelandii.
The present invention also comprises the use of the thus modified alginates for immobilizing enzymes, cell organelles and cells by entrapment in gels of alginate or alginate having suitable cations, as well as by immobi¬ lizing biocatalysts by encapsulation in alginate poly- cation microcapsules .
The mannuronan-C-5-epimerase may be isolated from cultures from the earth bacterium Azotobacter vinelandii. which produces both alginate and epimerase extracellu- larily. The fact that the enzyme is extracellular is a great advantage in the isolation process, and it also indicates that the enzyme may function freely in solution
independent on intracellular factors, which is favourable to a technical exploitation of the invention.
The use of immobilized enzymes as catalysts has obtained still greater importance in industry and will, in the years to come, become one of the most important expansion areas for biotechnology. Immobilized enzymes are often more stable, but first and foremost, they are easier to handle than free, soluble enzymes and may be used in continuous processes.
In addition to immobilizing simple enzymes there has also been developed techniques for immobilizing whole cells. The cells may serve as carriers for a single enzyme, such that isolation of the enzyme is unnecessary before immobilizing, or several enzymes may also be used in the cell in order to catalyse multistep processes (for instance synthesis of hormones, proteins, etc.).
We have tried out the epi erizing of a plurality of high polymer alga and bacterium alginates having varying block structures and formulation, and the conclusions are that all of the alginates can be epimerized to a substantial degree. The epimerization degree varies from 60 to 90 percent depending on the original block structure of the alginates and for some alginates this yields more than a doubling of the gel strength measured in 2 percent homogenous Ca-alginate gels .
Examples
Example 1
Sodium alginate derived from Laminaria diσitata, in an amount of 0.07% by weight, was dissolved in cationic buffer, 0.05 collidine pH 7.0 and Ca2+ 6.8mM. This was incubated with a lyase-free C-5-epimerase preparation from A. vinelandii at 30°C for 8 hours. The epimerization degree, measured by means of high solution n.m.r. -spectro- scopy, shows an increase of the guluronic acid content from 41% to 69% (see the Table) .
Example 2
Sodium alginate from Macrocvstis pyrifera, in an amount of 0.07% by weight, was dissolved in cationic buffer, 0.05M collidine pH 7.0 and Ca2+ 6.8mM. This was incubated with a lyase-free C-5-epimerase preparation from A. vinelandii at 30°C for 8 hours. The epimerization degree, measured by means of high solution n.m.r.-spectro- scopy, shows an increase of the guluronic acid content from 37% to 62% (see the Table).
Example 3
Sodium alginate from Laminaria hvperborea, in an amount of 0.07% by weight was dissolved in a cationic
2+ buffer, 0.05M collidine pH 7.0 and Ca 6.8mM. This was incubated with a lyase-free C-5-epimerase preparation from
A. vinelandii at 30°C for 8 hours. The epimerization degree, measured by means of high solution n.m. . -spectro- scopy, shows an increase of the guluronic acid content from 68% to 79% (see the Table) .
Example 4
Sodium alginate from Laminaria diαitata containing 40° guluronic acid is treated with C-5-epimerase from A. vinelandii at pH 7.0 and Ca2+ 0.68mM for 6 hours at 30°C. The modified alginate contains 63% guluronic acid. Gel strength measurements on homogenous 2% calcium gels show a gel strength of 3.8 N/cm 2 and 9.6 N/cm2 in native and enzyme modified alginate, respectively (see Figure 1) .
TABLE
Composition and GG content of the polymer before and after enzymatic modification measured by 1 high solution H-n.m.r. -spectroscopy
Before After
Source epimerization epimerization
M GG M GG
Laminaria dicritata 0. .41 0.59 0. .25 0.69 0.31 0.54
Laminaria hvoerborea 0. .68 0.32 0. .57 0.79 0.21 0.67
Macrocvstis pyrifera 0. .37 0.63 0. .14 0.62 0.38 0.32
Elachistae so. 0. .68 0.32 0. .64 0.89 0.11 0.85
Dichtiosvphon foenicula. 0 0.. .6677 0.33 0. .61 0.81 0.19 0.75
Ascophyllum nodosum 0. .36 0.64 0. .16 0.63 0.37 0.39
Azotobacter vinelandii 0. .45 0.55 0. ,41 0.69 0.33 0.54 deacetylated
Claims
1. A process for producing alginates having improved physical properties, for instance increased gel strength, comprising inoculating alginates derived from brown algae or bacteria with an enzyme preparation.
2. The process of claim 1, wherein said enzyme prepa¬ ration is a C-5-epimerase preparation.
3. The process of claim 1 or 2, wherein said mannuronan-C-5epimerase preparation is derived from Azotobacter vinelandii.
4. The use of alginates modified by the process according to any one of the preceding claims, for immobilizing enzymes, cell organelles and cells by gel entrapment in alginate gels or microcapsules of alginate and poly- cations.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO845059A NO845059L (en) | 1984-12-17 | 1984-12-17 | PROCEDURE FOR PREPARING ALGINATES WITH CHANGED PHYSICAL PROPERTIES AND USING THESE ALGINATES. |
NO845059 | 1984-12-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1986003781A1 true WO1986003781A1 (en) | 1986-07-03 |
Family
ID=19887997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NO1985/000080 WO1986003781A1 (en) | 1984-12-17 | 1985-12-16 | Process for producing alginates having improved physical properties, and the use of said alginates |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0204805A1 (en) |
NO (1) | NO845059L (en) |
WO (1) | WO1986003781A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988002758A1 (en) * | 1986-10-17 | 1988-04-21 | Protan A/S | Modification of alginates or other uronic acid compounds by treatment with co2 |
WO1994009124A1 (en) * | 1992-10-08 | 1994-04-28 | Pronova Biopolymer A.S | Dna compounds comprising sequences encoding mannuronan c-5-epimerase |
FR2849056A1 (en) * | 2002-12-19 | 2004-06-25 | Centre Nat Rech Scient | New isolated nucleic acid encoding mannuronan C5-epimerase, useful for modifying alginate and similar polymers to regulate gelling and other physical properties, also derived recombinant enzyme |
WO2005120589A2 (en) * | 2004-06-14 | 2005-12-22 | Ntnu Technology Transfer | Contrast agent comprising alginate and an isotope or paramagnetic ion |
WO2006051421A1 (en) * | 2004-11-12 | 2006-05-18 | Fmc Biopolymer As | Modified alginates, methods of production and use |
WO2008004890A2 (en) | 2006-07-04 | 2008-01-10 | Spermvital As | Preservation and controlled delivery/release of spermatozoa |
WO2013076232A1 (en) | 2011-11-24 | 2013-05-30 | Spermvital As | Methods for the preparation of hydrogels using lipase enzymes |
US9422373B2 (en) | 2011-06-02 | 2016-08-23 | Massachusetts Institute Of Technology | Modified alginates for cell encapsulation and cell therapy |
US9446168B2 (en) | 2010-06-07 | 2016-09-20 | Beta-O2 Technologies Ltd. | Multiple-layer immune barrier for donor cells |
US9540630B2 (en) | 2008-09-17 | 2017-01-10 | Beta O2 Technologies Ltd. | Optimization of alginate encapsulation of islets for transplantation |
WO2018104160A1 (en) | 2016-12-05 | 2018-06-14 | Spermvital As | Sustained release composition |
WO2019234010A1 (en) | 2018-06-04 | 2019-12-12 | Spermvital As | Functionalized kit for preparing hydrogels |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU742434A1 (en) * | 1978-10-11 | 1980-06-25 | Ленинградский ордена Трудового Красного Знамени институт текстильной и легкой промышленности им.С.М.Кирова | Method of preparing immobilized peroxydase |
JPS5974984A (en) * | 1982-10-21 | 1984-04-27 | Sumitomo Chem Co Ltd | Preparation of immobilized enzyme or microorganism |
-
1984
- 1984-12-17 NO NO845059A patent/NO845059L/en unknown
-
1985
- 1985-12-16 WO PCT/NO1985/000080 patent/WO1986003781A1/en unknown
- 1985-12-16 EP EP19860900291 patent/EP0204805A1/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU742434A1 (en) * | 1978-10-11 | 1980-06-25 | Ленинградский ордена Трудового Красного Знамени институт текстильной и легкой промышленности им.С.М.Кирова | Method of preparing immobilized peroxydase |
JPS5974984A (en) * | 1982-10-21 | 1984-04-27 | Sumitomo Chem Co Ltd | Preparation of immobilized enzyme or microorganism |
Non-Patent Citations (14)
Title |
---|
BIOCHIM. BIOPHYS. ACTA, vol. 192, no. 3, 1969, pages 557 - 559 * |
CARBOHYD. RES., vol. 17, no. 2, 1971, pages 297 - 308 * |
CARBOHYD. RES., vol. 20, no. 2, 1971, pages 225 - 232 * |
CHEMICAL ABSTRACTS, vol. 101, 1984, Columbus, Ohio, US; abstract no. 166114U * |
CHEMICAL ABSTRACTS, vol. 72, 1970, Columbus, Ohio, US; abstract no. 75879P * |
CHEMICAL ABSTRACTS, vol. 75, 1971, Columbus, Ohio, US; abstract no. 564K * |
CHEMICAL ABSTRACTS, vol. 76, 1972, Columbus, Ohio, US; abstract no. 31806R * |
CHEMICAL ABSTRACTS, vol. 82, 1975, Columbus, Ohio, US; abstract no. 167310F * |
CHEMICAL ABSTRACTS, vol. 95, 1981, Columbus, Ohio, US; abstract no. 147178J * |
DATABASE WPI Derwent World Patents Index; AN 1981-13334D/08 * |
GUMS. STAB. FOOD IND. APPL. HYDROCOLLOIDS; PROC. INT. CONF. 2ND 1983, 1984, pages 523 - 528 * |
NIPPON SUISAN GAKKAISHA, vol. 47, no. 7, 1981, pages 889 - 893 * |
PATENT ABSTRACTS OF JAPAN * |
PROC. INT. SEAWEED SYMP. 7TH 1971, 1972, pages 491 - 495 * |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988002758A1 (en) * | 1986-10-17 | 1988-04-21 | Protan A/S | Modification of alginates or other uronic acid compounds by treatment with co2 |
WO1994009124A1 (en) * | 1992-10-08 | 1994-04-28 | Pronova Biopolymer A.S | Dna compounds comprising sequences encoding mannuronan c-5-epimerase |
US5939289A (en) * | 1992-10-08 | 1999-08-17 | Pronova Biopolymer A.S. | DNA compounds comprising sequences encoding mannuronan C-5-epimerase |
KR100338997B1 (en) * | 1992-10-08 | 2002-11-11 | 에프엠씨 바이오폴리머 아에스 | DNA Compounds Containing Sequence Encoding Mannuronan (C) -5-Epimerase |
FR2849056A1 (en) * | 2002-12-19 | 2004-06-25 | Centre Nat Rech Scient | New isolated nucleic acid encoding mannuronan C5-epimerase, useful for modifying alginate and similar polymers to regulate gelling and other physical properties, also derived recombinant enzyme |
WO2004065594A3 (en) * | 2002-12-19 | 2005-04-07 | Centre Nat Rech Scient | Mannuronan c5-epimerases of brown algae, methods of obtaining same and use thereof |
WO2004065594A2 (en) * | 2002-12-19 | 2004-08-05 | Centre National De La Recherche Scientifique (C.N.R.S.) | Mannuronan c5-epimerases of brown algae, methods of obtaining same and use thereof |
WO2005120589A3 (en) * | 2004-06-14 | 2006-06-15 | Ntnu Technology Transfer | Contrast agent comprising alginate and an isotope or paramagnetic ion |
WO2005120589A2 (en) * | 2004-06-14 | 2005-12-22 | Ntnu Technology Transfer | Contrast agent comprising alginate and an isotope or paramagnetic ion |
JP2008519595A (en) * | 2004-11-12 | 2008-06-12 | エフエムシー バイオポリマー エイエス | Modified alginate and production method and use thereof |
WO2006051421A1 (en) * | 2004-11-12 | 2006-05-18 | Fmc Biopolymer As | Modified alginates, methods of production and use |
WO2008004890A2 (en) | 2006-07-04 | 2008-01-10 | Spermvital As | Preservation and controlled delivery/release of spermatozoa |
US9540630B2 (en) | 2008-09-17 | 2017-01-10 | Beta O2 Technologies Ltd. | Optimization of alginate encapsulation of islets for transplantation |
US9446168B2 (en) | 2010-06-07 | 2016-09-20 | Beta-O2 Technologies Ltd. | Multiple-layer immune barrier for donor cells |
US10285949B2 (en) | 2011-06-02 | 2019-05-14 | Massachusetts Institute Of Technology | Modified alginates for cell encapsulation and cell therapy |
US9422373B2 (en) | 2011-06-02 | 2016-08-23 | Massachusetts Institute Of Technology | Modified alginates for cell encapsulation and cell therapy |
US11337930B2 (en) | 2011-06-02 | 2022-05-24 | Massachusetts Institute Of Technology | Modified alginates for cell encapsulation and cell therapy |
US10842753B2 (en) | 2011-06-02 | 2020-11-24 | Massachusetts Institute Of Technology | Modified alginates for cell encapsulation and cell therapy |
US10292936B2 (en) | 2011-06-02 | 2019-05-21 | Massachusetts Institute Of Technology | Modified alginates for cell encapsulation and cell therapy |
WO2013076232A1 (en) | 2011-11-24 | 2013-05-30 | Spermvital As | Methods for the preparation of hydrogels using lipase enzymes |
US10041059B2 (en) | 2011-11-24 | 2018-08-07 | Spermvital As | Methods for the preparation of hydrogels |
US9578871B2 (en) | 2011-11-24 | 2017-02-28 | Spermvital As | Methods for the preparation of hydrogels using lipase enzymes |
WO2018104160A1 (en) | 2016-12-05 | 2018-06-14 | Spermvital As | Sustained release composition |
WO2019234010A1 (en) | 2018-06-04 | 2019-12-12 | Spermvital As | Functionalized kit for preparing hydrogels |
US11957123B2 (en) | 2018-06-04 | 2024-04-16 | Spermvital As | Functionalized kit for preparing hydrogels |
Also Published As
Publication number | Publication date |
---|---|
NO845059L (en) | 1986-06-18 |
EP0204805A1 (en) | 1986-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Guiseley | Chemical and physical properties of algal polysaccharides used for cell immobilization | |
Draget et al. | Alginate based new materials | |
Moradali et al. | Alginate biosynthesis and biotechnological production | |
Bucke | Immobilized cells | |
WO1986003781A1 (en) | Process for producing alginates having improved physical properties, and the use of said alginates | |
Thu et al. | Alginate gels-Some structure-function correlations relevant to their use as immobilization matrix for cells | |
CN109554360B (en) | Method for embedding thalli by using sodium alginate composite material | |
Zhang et al. | Purification and characterization of β-mannanase from Bacillus licheniformis for industrial use | |
CN105431534A (en) | beta-1,3-glucanase, polynucleotide, recombinant vector, transformant, production method for beta-1,3-glucanase, enzyme preparation, and production method for paramylon having reduced molecular weight | |
Paul et al. | Photophosphorylation in bacterial chromatophores entrapped in alginate gel: improvement of the physical and biochemical properties of gel beads with barium as gel-inducing agent | |
Vorlop et al. | [22] Entrapment of microbial cells in chitosan | |
Man et al. | Effects of culture conditions of immobilized recombinant Escherichia coli on cyclodextrin glucanotransferase (CGTase) excretion and cell stability | |
KR101207584B1 (en) | Strain of sanguibacter keddieii having an alginate-decomposition activity and method of producing alginate-oligomer using the same | |
West | Effect of carbon source on polysaccharide production by alginate‐entrapped Aureobasidium pullulans ATCC 42023 cells | |
West | Exopolysaccharide production by entrapped cells of the fungus Aureobasidium pullulans ATCC 201253 | |
Zevenhuizen | Gel-forming capsular polysaccharide of fast-growing rhizobia: occurrence and rheological properties | |
Qader et al. | Continuous production of dextran from immobilized cells of Leuconostoc mesenteroides KIBGE HA1 using acrylamide as a support | |
CA1215336A (en) | Immobilization of catalytically active microorganisms in agar gel fibers | |
Hashem et al. | Immobilization of Leuconostoc-paramesenteroides dextransucrase enzyme and characterization of its enzyme properties | |
US20240102062A1 (en) | Method for producing tagatose by immobilized multi-enzyme system | |
Murata et al. | Continuous depolymerization of alginates by a non-support bioreactor system containing flocculated bacterial cells | |
JPS5974984A (en) | Preparation of immobilized enzyme or microorganism | |
Ramírez-Tapias et al. | Biodegradation of vegetable residues by polygalacturonase-agar using a trickle-bed bioreactor | |
Otady et al. | Gum tragacanth gels as a new supporting matrix for immobilization of whole-cell | |
Ziayoddin et al. | Isolation of agar degrading bacterium Pseudomonas aeruginosa ZSL-2 from a marine sample |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |